Skip to main content
Microba Life Sciences Limited (ASX:MAP)
Australia flag Australia · Delayed Price · Currency is AUD
0.0700
+0.0030 (4.48%)
Apr 29, 2026, 3:32 PM AEST

Microba Life Sciences Revenue

Microba Life Sciences had revenue of 7.32M AUD in the half year ending December 31, 2025, with 123.66% growth. This brings the company's revenue in the last twelve months to 14.90M, down -11.81% year-over-year. In the fiscal year ending June 30, 2025, Microba Life Sciences had annual revenue of 15.67M with 29.60% growth.

Revenue (ttm)
14.90M
Revenue Growth
-11.81%
P/S Ratio
2.74
Revenue / Employee
n/a
Employees
n/a
Market Cap
40.80M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 202515.67M3.58M29.60%
Jun 30, 202412.09M6.67M123.06%
Jun 30, 20235.42M731.49K15.60%
Jun 30, 20224.69M956.20K25.62%
Jun 30, 20213.73M823.42K28.31%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
INOVIQ 2.10M
Cryosite 15.75M
Genetic Signatures 19.94M
BCAL Diagnostics 2.54M
Rhythm Biosciences 1.65M
Imagion Biosystems 73.03K
Monash IVF Group 269.39M
Genetic Technologies 9.17M
Revenue Rankings

Microba Life Sciences News

More News